GlaxoSmithKline
GSK
#250
Rank
A$118.73 B
Marketcap
$58.64
Share price
-0.19%
Change (1 day)
-7.98%
Change (1 year)

GlaxoSmithKline (GSK) Fails to deliver data

Key failure to deliver metrics for GlaxoSmithKline:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for GlaxoSmithKline (GSK) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for GlaxoSmithKline (GSK) - since 2022

Volume in USD (price x number of shares), data since 2022

GlaxoSmithKline (GSK) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025A$0.14 B0.29%
2024A$0.14 B395%
2023A$29.9 M-43.98%
2022A$53.37 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
A$38.06 MA$0.12 B๐Ÿ‡ฌ๐Ÿ‡ง UK
A$33.22 MA$0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$57.2 MA$0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA
A$44.97 MA$0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$6.82 MA$53.35 M๐Ÿ‡ซ๐Ÿ‡ท France
A$12.18 MA$42.24 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
A$0.53 MA$32.53 M๐Ÿ‡บ๐Ÿ‡ธ USA